Niacin (nicotinic acid) decreased Lp(a) by about 28% in a small clinical trial.
Link to full study:
Paper · Atheroscler Suppl · 2015Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.Conclusion: High-dose ER niacin declines elevated Lp(a) level in male subjects with low- but not high-molecular weight apo(a) phenotype.pubmed.ncbi.nlm.nih.govNote that niacin failed to improve outcomes in two large trials when combined with high-dose statins, but did increase side effects. It should not be combined with high-dose statins.



